These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6761249)

  • 41. Mutagenicity evaluation of azaperone in the Salmonella/microsome test.
    Duverger-van Bogaert M; Vanparys P; de Meester C; Marsboom R
    Drug Chem Toxicol; 1987; 10(3-4):329-38. PubMed ID: 3322780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW; Lijinsky W; Snyder SW
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutagenicity of aminocarbazoles and nitrocarbazoles.
    LaVoie EJ; Govil A; Briggs G; Hoffmann D
    Mutat Res; 1981 Dec; 90(4):337-44. PubMed ID: 7038457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenic activation of 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole(Trp-P-1) and 3-amino-1-methyl-5H-pyrido(4,3-b)indole (Trp-P-2) by primary cultures of adult rat hepatocytes: effect of Aroclor induction in vitro.
    Decloître F; Hamon G; Martin M; Thybaud-Lambay V
    Mutat Res; 1984; 137(2-3):123-32. PubMed ID: 6433191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determining the mutagenic activity of a tar, its vapors and aerosols.
    Penalva JM; Chalabreysse J; Archimbaud M; Bourgineau G
    Mutat Res; 1983 Apr; 117(1-2):93-104. PubMed ID: 6339912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic activation and inactivation of metanil yellow and orange II in the Salmonella typhimurium his-reversion assay.
    Rastogi PB; Levin RE
    J Food Prot; 1996 Mar; 59(3):244-8. PubMed ID: 10463440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.
    Sezzano P; Raimondi A; Arboix M; Pantarotto C
    Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutagenic activity at different stages of an industrial ammonia caramel process detected in Salmonella typhimurium TA100 following pre-incubation.
    Jensen NJ; Willumsen D; Knudsen I
    Food Chem Toxicol; 1983 Oct; 21(5):527-30. PubMed ID: 6360827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of release from hepatocytes in vitro or excretion in vivo of mutagenic chrysoidine metabolites.
    Sandhu P; Chipman JK
    Toxicol Lett; 1991 Sep; 58(1):43-50. PubMed ID: 1897005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bile acids: co-mutagenic activity in the Salmonella-mammalian-microsome mutagenicity test: brief communication.
    Silverman SJ; Andrews AW
    J Natl Cancer Inst; 1977 Nov; 59(5):1557-9. PubMed ID: 909111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutagenicity of tetramic mycotoxin cyclopiazonic acid.
    Sorenson WG; Tucker JD; Simpson JP
    Appl Environ Microbiol; 1984 Jun; 47(6):1355-7. PubMed ID: 6430233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Salmonella mutagenicity test: evaluation of 29 drug candidates.
    Aaron CS; Mazurek J; Zimmer DM; Swenson DH
    Mutat Res; 1989 Jun; 223(2):171-82. PubMed ID: 2662001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100.
    Prasanna P; Jacobs MM; Yang SK
    Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538.
    Yamada M; Espinosa-Aguirre JJ; Watanabe M; Matsui K; Sofuni T; Nohmi T
    Mutat Res; 1997 Apr; 375(1):9-17. PubMed ID: 9129675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
    Suter W; Matter-Jaeger I
    Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural specificity of aromatic compounds with special reference to mutagenic activity in Salmonella typhimurium--a series of chloro- or fluoro-nitrobenzene derivatives.
    Shimizu M; Yasui Y; Matsumoto N
    Mutat Res; 1983 Mar; 116(3-4):217-38. PubMed ID: 6339893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative mutagenicity studies of azo dyes and their reduction products in Salmonella typhimurium.
    Krishna G; Xu J; Nath J
    J Toxicol Environ Health; 1986; 18(1):111-9. PubMed ID: 3517355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenicity of furoquinoline alkaloids in the Salmonella/microsome assay. Mutagenicity of dictamnine is modified by various enzyme inducers and inhibitors.
    Häfele F; Schimmer O
    Mutagenesis; 1988 Jul; 3(4):349-53. PubMed ID: 3062325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of alkoxy substituents on the mutagenicity of some phenylenediamine-based disazo dyes.
    Esancy JF; Freeman HS; Claxton LD
    Mutat Res; 1990 Jan; 238(1):23-38. PubMed ID: 2406583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.